COVID IS EXTREMELY DANGEROUS FOR CHOLESTEROL AND HEART PATIENTS
INDER PRATAP SINGH
![INDER PRATAP SINGH]()
INDER PRATAP SINGH
LOGISTICS AND SUPPLY CHAIN ENTHUSIAST | MECHANICAL ENGINEER | DIGITAL MARKETER
- Speculation with respect to poorer outcomes for those with huge cholesterol and/or heart disease affected with SARS-CoV-2 are well known.
- This week, a real-world study published by the FH Foundation confirms COVID-19 enlarged heart attack rates accordingly in patients with these conditions.
- Familial hypercholesterolemia is a familiar yet severely underdiagnosed genetic condition. While those with large cholesterol are commonly considered to be elevated due to age, lifestyle, and diet, FH patients experience elevated LDL from birth.
- Researchers say only 10% of the estimated 1.3 million with FH have accepted a diagnosis due to lack of awareness.
- The condition raises the risk of cardiovascular disease by up to 20-fold due to the permanent elevation of LDL cholesterol.
- Adopting a machine learning process dubbed "FIND FH," the FH Foundation inspected a share of over 55.4 million individuals – those with diagnosed FH, probable FH, and atherosclerotic cardiovascular disease (ASCVD) - with and without COVID-19 infection.
- The study begins that the "probable FH" individuals with pre-existing ASCVD affected with COVID experienced heart attacks at the maximum rate, seven times larger than those who did not get the virus.
- These results are powerful because these data underscore the attention of awareness if individuals have underlying cardiovascular disease or genetic soaring cholesterol when handling COVID-19 infection or considering vaccination.
- According to one author of the study, the "probable FH" patients are attainable not to acquire lipid-lowering treatment. Genetic soaring cholesterol cannot be well-managed by diet and exercise alone.
- This research is a call to action to diagnose individuals with this bloody genetic condition who are hiding in plain sight within our healthcare system and take distinct precautions detailing Covid-19 infections.
- In November, BioSpace announces a JAMA investigation that proved COVID-19 is a cardiac condition as it is a respiratory disease.
- SARS-CoV-2 causes heart destruction in 20% of people with mild or no symptoms. Many medications are accessible for the treatment of FH. The key is diagnosis.
- Additionally, individuals with FH and ASVCD should take extra care to avoid contracting the novel coronavirus, which has swept our globe for well over a year.
- Vaccinations are readily accessible in many countries and growing into those less accessible areas as well.
- The CDC is planning to meet to regulate if COVID-19 vaccines will need boosters to support avoid the circulate of variants, some of which have changed into more poisonous and more deadly than the authentic strain.